5 Key Takeaways

• 1

  One-third of patients with anti-NMDAR encephalitis struggle to return to work or education due to persistent cognitive and emotional challenges.

• 2

  The study assessed long-term outcomes in 92 patients, predominantly young adults, with a mean age of 29 years.

• 3

  Cognitive recovery continued for up to 36 months, with significant improvements noted in the first six months post-diagnosis.

• 4

  By 36 months, 34% of patients had cognitive impairments in one or more domains, and 65% scored below average in at least one cognitive area.

• 5

  Treatment with intravenous immunoglobulin was positively associated with quality of life, with median EQ-5D-5L scores of 0.90 versus 0.72.